<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01968447</url>
  </required_header>
  <id_info>
    <org_study_id>NL45461.058.13</org_study_id>
    <nct_id>NCT01968447</nct_id>
  </id_info>
  <brief_title>Effect of Neuromuscular Block and Arterial PCO2 on Surgical Rating Scale (SRS), Following Reversal With Sugammadex</brief_title>
  <acronym>BLISSS2</acronym>
  <official_title>Effect of Deep Neuromuscular Block and Variations in Arterial PCO2 on the Surgical Rating Scale (SRS), Extubation Conditions and Postoperative Conditions Following Reversal With Sugammadex</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Leiden University Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Merck Sharp &amp; Dohme Corp.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Leiden University Medical Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to study the effect of variations in the arterial CO2
      concentration during deep neuromuscular block on the surgical conditions as assessed by the
      surgical rating scale
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Surgical conditions in laparoscopic surgery are largely determined by the depth of
      neuromuscular relaxation during surgery. This is especially true in procedures which are
      confined to a narrow working field such as retroperitoneal laparoscopic surgery (eg. renal
      and prostatic surgery). In the previous study (BLISS study) deep neuromuscular block (NMB)
      has shown to provide superior surgical conditions compared to moderate NMB. Moreover, rapid
      reversal of a deep NMB at the end of surgery was possible with Sugammadex (4mg/kg). The deep
      NMB did not lead to any delay in extubation time and did not cause any prolongation of stay
      in the recovery room when the block was reversed with Sugammadex

      Rapid, safe and complete reversal of profound NMB blockade was not possible until the
      discovery of Sugammadex. Sugammadex is a modified Î³-cyclodextrin. It was developed to
      selectively bind free plasma rocuronium, a non-depolarizing steroidal neuromuscular blocking
      agent. The BLISS study was the first study in which the effect of deep NMB on surgical
      conditions was assessed. Surgical conditions in this study were scored by one surgeon on a
      newly applied surgical rating scale which ranges from one to five.

      Although the BLISS study showed that a deep NMB provided better surgical conditions than a
      moderately deep NMB overall, there was a high variability in surgical rating scores. More
      over, even at the deep NMB, SRS scores of 3 (moderate, but acceptable conditions) were noted.
      This indicates that surgical conditions are influenced by other factors as well. Involuntary
      movement of the diaphragm is possibly such a major disturbant of the surgical field. Previous
      studies have shown a relative resistance to neuromuscular blocking agents of the diaphragm
      compared to the musclus adductor pollicis on which neuromuscular block is generally
      monitored. Hence contractions of the diaphragm may occure despite a deep NMB. This may be due
      to (high) arterial carbon dioxide (CO2) concentrations, which stimulate the respiratory
      neuronal pool in the brainstem and consequently activate the phrenic nerve. In normal
      circumstances, the respiratory centers try to maintain an arterial CO2 pressure of 40 mmHg.
      With intentional hyperventilation, the arterial CO2 pressure may be lowered to 10-20 mmHg. A
      low arterial CO2 pressure diminishes the respiratory drive and consequently phrenic nerve
      activity. This is supported by previous observations which showed increased abdominal muscle
      relaxation produced by hyperventilation. We therefore designed this study to evaluate the
      effect of arterial CO2 variation with concurrent deep NMB on the surgical conditions.
      Arterial CO2 tensions may be altered by adjusting the ventilator settings. Eg. by increasing
      minute ventilation volume, arterial CO2 concentration will lower. Regular arterial blood
      samples will be drawn to monitor arterial CO2 concentration.

      We hypothesize that a Deep NMB combined with hypocapnia will result in a significant
      improvement of surgical conditions as rated on the surgical rating scale by one surgeon
      compared to deep NMB and normocapnia

      Additional secondary end-points of the study include the effect of arterial CO2 variation on:

        -  economic parameters (time to spontaneous breathing, time to extubation, duration of
           surgery, and time in the post-anesthesia care unit)

        -  perioperative hemodynamics, abdominal pressure

        -  postoperative conditions (respiratory conditions, hemodynamics, arterial oxygen
           saturation, pain, sedation, nausea and vomiting)

        -  To assess the ability of anesthesiologists and surgeons to rate the surgical field using
           video snippets of the surgical field.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>February 2014</start_date>
  <completion_date type="Actual">October 2015</completion_date>
  <primary_completion_date type="Actual">October 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Surgical Rating Scale</measure>
    <time_frame>Peroperative</time_frame>
    <description>During a procedure, the surgical condition will be scored by one surgeon using a 5-point surgical rating scale. The rating scale is a 5-point ordinal scale ranging from 1 = poor condition to 5 = optimal surgical conditions. The surgeon will score the condition at 15 minute intervals.The values given on the surgical rating scale are averaged and the average value is used in the data analysis.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Hemodynamics</measure>
    <time_frame>peroperative</time_frame>
    <description>Hemodynamic conditions are studied during low arterial CO2 concentration and normal arterial CO2 concentration. The average of the measured mean arterial pressures at 15 minute intervals during anesthesia are presented</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Respiratory Function</measure>
    <time_frame>from the end of surgery untill 2 hours postoperative</time_frame>
    <description>The effect of low versus normal pCO2 concentrations on the postoperative respiratory function will be studied. Postoperative saturations are obtained at 15 minutes intervals. The data are averaged over time.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain Intensity on an 11-point Scale in the Postoperative Period</measure>
    <time_frame>from the end of surgery untill 2 hours postoperative</time_frame>
    <description>The effect of low versus normal pCO2 concentrations on postoperative pain will be studied. Painscores are obtained at 15 minutes intervals and are expressed as a number on a 10 point scale (numeric rating scale; 1 (low)-10(maximum)). The data is avaraged over time</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sedation</measure>
    <time_frame>from the end of surgery untill 2 hours postoperative</time_frame>
    <description>The effect of low versus normal pCO2 concentrations on postoperative sedation will be studied using the using the validated Leiden Observer's Assessment of Alertness/Sedation (0 (awake) - 6 (unarousable)) scale at 15 min intervals. The data are averaged over time.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Nausea</measure>
    <time_frame>from the end of surgery untill 2 hours postoperative</time_frame>
    <description>The effect of low versus normal pCO2 concentrations on the incidence of postoperative nausea will be studied. The incidence is expressed as the percentage of people experiencing nausea per arm.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Vomiting</measure>
    <time_frame>from the end of surgery untill 2 hours postoperative</time_frame>
    <description>The effect of low versus normal pCO2 concentrations on the incidence of postoperative vomiting will be studied. The incidence of vomiting is expressed as a precentage of the patients per arm.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">40</enrollment>
  <condition>Prostate Cancer</condition>
  <condition>Renal Cancer</condition>
  <arm_group>
    <arm_group_label>hypocapnia</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>arterial pCO2 of 3.5 kPa</description>
  </arm_group>
  <arm_group>
    <arm_group_label>normocapnia</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>arterial PCO2 of 6.5-7.0 kPa</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>hypocapnia</intervention_name>
    <description>Hyperventilation to the level of hypocapnia</description>
    <arm_group_label>hypocapnia</arm_group_label>
    <other_name>Low CO2</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>normocapnia</intervention_name>
    <description>Normal ventilation to the level of nromocapnia</description>
    <arm_group_label>normocapnia</arm_group_label>
    <other_name>normal CO2</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  (i) Patients diagnosed with renal or prostatic disease who are will undergo an
             elective laparoscopic renal surgical procedure or laparoscopic prostatectomy;

          -  (ii) ASA class I-III

          -  (iii) &gt; 18 years of age;

          -  (iv) Ability to give oral and written informed consent.

        Exclusion Criteria:

          -  (i) Known or suspected neuromuscular disorders impairing neuromuscular function;

          -  (ii) Allergies to muscle relaxants, anesthetics or narcotics;

          -  (iii) A (family) history of malignant hyperthermia;

          -  (iv) Women who are or may be pregnant or are currently breast feeding;

          -  (v) Renal insufficiency, as defined by serum creatinine x 2 of normal, or urine output
             &lt; 0.5 ml/kg/h for at least 6 h. When available, other indices will be taken into
             account as well such as glomerular filtration rate &lt; 60 ml/h and proteinuria (a ratio
             of 30 mg albumin to 1 g of creatinine).

          -  (vi) Previous retroperitoneal surgery at the site of the current surgery.

          -  (vii) Body mass index &gt; 35 kg/m2

          -  (viii) Chronic obstructive pulmonary disease GOLD 2-4 or a FEV1 less than 70%
             predicted or VC less than 70% predicted

          -  (ix) chronic pulmonary disease with altered lung physiology (eg. sarcoidosis, cycstic
             fibrosis, obstructing pulmonary tumors, previous lung surgery)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Albert Dahan, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>LUMC</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Leiden University Medical Center</name>
      <address>
        <city>Leiden</city>
        <state>Zuid-Holland</state>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Netherlands</country>
  </location_countries>
  <verification_date>February 2020</verification_date>
  <study_first_submitted>October 7, 2013</study_first_submitted>
  <study_first_submitted_qc>October 19, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 24, 2013</study_first_posted>
  <results_first_submitted>December 6, 2015</results_first_submitted>
  <results_first_submitted_qc>February 29, 2020</results_first_submitted_qc>
  <results_first_posted type="Actual">March 16, 2020</results_first_posted>
  <last_update_submitted>February 29, 2020</last_update_submitted>
  <last_update_submitted_qc>February 29, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">March 16, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Leiden University Medical Center</investigator_affiliation>
    <investigator_full_name>Albert Dahan</investigator_full_name>
    <investigator_title>Prof. Dr.</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Kidney Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Hypocapnia</title>
          <description>arterial pCO2 of 3.5 kPa or 26.3 mmHg
hypocapnia</description>
        </group>
        <group group_id="P2">
          <title>Normocapnia</title>
          <description>arterial PCO2 of 6.5-7.0 kPa or 48.8-52.5 mmHg
normocapnia</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="20"/>
                <participants group_id="P2" count="20"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="20"/>
                <participants group_id="P2" count="20"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Hypocapnia</title>
          <description>arterial pCO2 of 3.5 kPa or 26.3 mmHg
hypocapnia</description>
        </group>
        <group group_id="B2">
          <title>Normocapnia</title>
          <description>arterial PCO2 of 6.5-7.0 kPa or 48.8-52.5 mmHg
normocapnia</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="20"/>
            <count group_id="B2" value="20"/>
            <count group_id="B3" value="40"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="10"/>
                    <measurement group_id="B2" value="12"/>
                    <measurement group_id="B3" value="22"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="10"/>
                    <measurement group_id="B2" value="8"/>
                    <measurement group_id="B3" value="18"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Median</param>
          <dispersion>Full Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="65" lower_limit="22" upper_limit="80"/>
                    <measurement group_id="B2" value="62" lower_limit="25" upper_limit="72"/>
                    <measurement group_id="B3" value="64" lower_limit="22" upper_limit="80"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                    <measurement group_id="B2" value="6"/>
                    <measurement group_id="B3" value="9"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="17"/>
                    <measurement group_id="B2" value="14"/>
                    <measurement group_id="B3" value="31"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Netherlands</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="20"/>
                    <measurement group_id="B2" value="20"/>
                    <measurement group_id="B3" value="40"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Surgical Rating Scale</title>
        <description>During a procedure, the surgical condition will be scored by one surgeon using a 5-point surgical rating scale. The rating scale is a 5-point ordinal scale ranging from 1 = poor condition to 5 = optimal surgical conditions. The surgeon will score the condition at 15 minute intervals.The values given on the surgical rating scale are averaged and the average value is used in the data analysis.</description>
        <time_frame>Peroperative</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Hypocapnia</title>
            <description>arterial pCO2 of 3.5 kPa or 26.3 mmHg
hypocapnia</description>
          </group>
          <group group_id="O2">
            <title>Normocapnia</title>
            <description>arterial PCO2 of 6.5-7.0 kPa or 48.8-52.5 mmHg
normocapnia</description>
          </group>
        </group_list>
        <measure>
          <title>Surgical Rating Scale</title>
          <description>During a procedure, the surgical condition will be scored by one surgeon using a 5-point surgical rating scale. The rating scale is a 5-point ordinal scale ranging from 1 = poor condition to 5 = optimal surgical conditions. The surgeon will score the condition at 15 minute intervals.The values given on the surgical rating scale are averaged and the average value is used in the data analysis.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
                <count group_id="O2" value="20"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.86" spread="0.4"/>
                    <measurement group_id="O2" value="4.75" spread="0.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other (legacy)</non_inferiority_type>
            <p_value>0.59</p_value>
            <method>Mixed Models Analysis</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Hemodynamics</title>
        <description>Hemodynamic conditions are studied during low arterial CO2 concentration and normal arterial CO2 concentration. The average of the measured mean arterial pressures at 15 minute intervals during anesthesia are presented</description>
        <time_frame>peroperative</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Hypocapnia</title>
            <description>arterial pCO2 of 3.5 kPa or 26.3 mmHg
hypocapnia</description>
          </group>
          <group group_id="O2">
            <title>Normocapnia</title>
            <description>arterial PCO2 of 6.5-7.0 kPa or 48.8-52.5 mmHg
normocapnia</description>
          </group>
        </group_list>
        <measure>
          <title>Hemodynamics</title>
          <description>Hemodynamic conditions are studied during low arterial CO2 concentration and normal arterial CO2 concentration. The average of the measured mean arterial pressures at 15 minute intervals during anesthesia are presented</description>
          <units>millimeters of mercury</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
                <count group_id="O2" value="20"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="85" spread="10"/>
                    <measurement group_id="O2" value="81" spread="9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Respiratory Function</title>
        <description>The effect of low versus normal pCO2 concentrations on the postoperative respiratory function will be studied. Postoperative saturations are obtained at 15 minutes intervals. The data are averaged over time.</description>
        <time_frame>from the end of surgery untill 2 hours postoperative</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Hypocapnia</title>
            <description>arterial pCO2 of 3.5 kPa or 26.3 mmHg
hypocapnia</description>
          </group>
          <group group_id="O2">
            <title>Normocapnia</title>
            <description>arterial PCO2 of 6.5-7.0 kPa or 48.8-52.5 mmHg
normocapnia</description>
          </group>
        </group_list>
        <measure>
          <title>Respiratory Function</title>
          <description>The effect of low versus normal pCO2 concentrations on the postoperative respiratory function will be studied. Postoperative saturations are obtained at 15 minutes intervals. The data are averaged over time.</description>
          <units>percentage of oxygen saturation</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
                <count group_id="O2" value="20"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="98.6" spread="2.1"/>
                    <measurement group_id="O2" value="98.5" spread="2.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Pain Intensity on an 11-point Scale in the Postoperative Period</title>
        <description>The effect of low versus normal pCO2 concentrations on postoperative pain will be studied. Painscores are obtained at 15 minutes intervals and are expressed as a number on a 10 point scale (numeric rating scale; 1 (low)-10(maximum)). The data is avaraged over time</description>
        <time_frame>from the end of surgery untill 2 hours postoperative</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Hypocapnia</title>
            <description>arterial pCO2 of 3.5 kPa or 26.3 mmHg
hypocapnia</description>
          </group>
          <group group_id="O2">
            <title>Normocapnia</title>
            <description>arterial PCO2 of 6.5-7.0 kPa or 48.8-52.5 mmHg
normocapnia</description>
          </group>
        </group_list>
        <measure>
          <title>Pain Intensity on an 11-point Scale in the Postoperative Period</title>
          <description>The effect of low versus normal pCO2 concentrations on postoperative pain will be studied. Painscores are obtained at 15 minutes intervals and are expressed as a number on a 10 point scale (numeric rating scale; 1 (low)-10(maximum)). The data is avaraged over time</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
                <count group_id="O2" value="20"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.1" spread="3.3"/>
                    <measurement group_id="O2" value="4.0" spread="3.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Sedation</title>
        <description>The effect of low versus normal pCO2 concentrations on postoperative sedation will be studied using the using the validated Leiden Observer's Assessment of Alertness/Sedation (0 (awake) - 6 (unarousable)) scale at 15 min intervals. The data are averaged over time.</description>
        <time_frame>from the end of surgery untill 2 hours postoperative</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Hypocapnia</title>
            <description>arterial pCO2 of 3.5 kPa or 26.3 mmHg
hypocapnia</description>
          </group>
          <group group_id="O2">
            <title>Normocapnia</title>
            <description>arterial PCO2 of 6.5-7.0 kPa or 48.8-52.5 mmHg
normocapnia</description>
          </group>
        </group_list>
        <measure>
          <title>Sedation</title>
          <description>The effect of low versus normal pCO2 concentrations on postoperative sedation will be studied using the using the validated Leiden Observer's Assessment of Alertness/Sedation (0 (awake) - 6 (unarousable)) scale at 15 min intervals. The data are averaged over time.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
                <count group_id="O2" value="20"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.4" spread="0.9"/>
                    <measurement group_id="O2" value="2.3" spread="0.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Nausea</title>
        <description>The effect of low versus normal pCO2 concentrations on the incidence of postoperative nausea will be studied. The incidence is expressed as the percentage of people experiencing nausea per arm.</description>
        <time_frame>from the end of surgery untill 2 hours postoperative</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Hypocapnia</title>
            <description>arterial pCO2 of 3.5 kPa or 26.3 mmHg
hypocapnia</description>
          </group>
          <group group_id="O2">
            <title>Normocapnia</title>
            <description>arterial PCO2 of 6.5-7.0 kPa or 48.8-52.5 mmHg
normocapnia</description>
          </group>
        </group_list>
        <measure>
          <title>Nausea</title>
          <description>The effect of low versus normal pCO2 concentrations on the incidence of postoperative nausea will be studied. The incidence is expressed as the percentage of people experiencing nausea per arm.</description>
          <units>percentage of patients</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
                <count group_id="O2" value="20"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.6"/>
                    <measurement group_id="O2" value="5.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Vomiting</title>
        <description>The effect of low versus normal pCO2 concentrations on the incidence of postoperative vomiting will be studied. The incidence of vomiting is expressed as a precentage of the patients per arm.</description>
        <time_frame>from the end of surgery untill 2 hours postoperative</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Hypocapnia</title>
            <description>arterial pCO2 of 3.5 kPa or 26.3 mmHg
hypocapnia</description>
          </group>
          <group group_id="O2">
            <title>Normocapnia</title>
            <description>arterial PCO2 of 6.5-7.0 kPa or 48.8-52.5 mmHg
normocapnia</description>
          </group>
        </group_list>
        <measure>
          <title>Vomiting</title>
          <description>The effect of low versus normal pCO2 concentrations on the incidence of postoperative vomiting will be studied. The incidence of vomiting is expressed as a precentage of the patients per arm.</description>
          <units>percentage of patients</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
                <count group_id="O2" value="20"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="3.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Hypocapnia</title>
          <description>arterial pCO2 of 3.5 kPa or 26.3 mmHg
hypocapnia</description>
        </group>
        <group group_id="E2">
          <title>Normocapnia</title>
          <description>arterial PCO2 of 6.5-7.0 kPa or 48.8-52.5 mmHg
normocapnia</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="20"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="20"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Albert Dahan</name_or_title>
      <organization>LUMC</organization>
      <phone>+31 71 52 62301</phone>
      <email>a.dahan@lumc.nl</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

